Mg29 activators are compounds designed to enhance the activity of the Mg29 protein, which is implicated in crucial cellular functions. The journey to identify and optimize these activators involves a sophisticated blend of biochemical, computational, and cellular techniques. The process typically starts with high-throughput screening, where a diverse library of molecules is tested for their ability to increase the activity of Mg29. This phase is critical for identifying lead compounds that show promise in modulating Mg29 activity positively. Once these leads are identified, they undergo a series of detailed molecular docking studies. These computational analyses provide insights into the interaction between the activators and the Mg29 protein, including potential binding sites and the nature of the interaction. Understanding how these activators bind to Mg29 is essential for elucidating their mechanism of action and for further chemical optimization to improve their efficacy and specificity.
In parallel to these in silico and in vitro studies, the effects of Mg29 activators are evaluated in cellular models. This involves using genetic engineering tools, such as CRISPR-Cas9, to modulate the expression levels of Mg29, creating an environment where the impact of activators can be observed under varying protein expressions. Additionally, fluorescent tagging techniques allow for the visualization of Mg29 within the cell, offering insights into how activators affect its localization and function in real time. These cellular studies are pivotal for validating the bioactivity of Mg29 activators observed in biochemical assays and computational models. They also provide a comprehensive view of how these compounds influence Mg29 activity in a living system, contributing to a deeper understanding of their potential as modulators of cellular processes. Through this multifaceted research approach, Mg29 activators are meticulously characterized, shedding light on their interactions with the target protein and paving the way for future investigations into their biological significance.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through its interaction with retinoic acid receptors, potentially influencing the expression of genes involved in synaptic function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels and may activate transcription factors associated with neuronal gene expression, possibly including SYPL2. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
As a kinase inhibitor, K252a could indirectly affect neuronal gene expression profiles, potentially altering SYPL2 expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in numerous signaling pathways, including those that may regulate genes like SYPL2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium modifies glycogen synthase kinase-3 (GSK-3) signaling and could affect synaptic protein gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is a known histone deacetylase inhibitor that can influence the epigenetic state of neuronal genes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can modulate epigenetic marks, which may affect the expression of synaptic proteins, potentially including SYPL2. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
This compound is a histone deacetylase inhibitor that can alter gene expression by affecting chromatin structure. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
As a hormone with widespread gene regulatory functions, beta-estradiol could influence the expression of neuronal genes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects various signaling pathways and might modulate neuronal gene expression. | ||||||